Track Zhengye Biotechnology Holding Limited's long-term debt ($9.2M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Zhengye Biotechnology Holding Limited (ZYBT) currently reports a long-term debt of $9.2M as of December 2025. That compares with $4.8M in the prior-year period — up 91.2% year over year. Use the charts on this page to explore Zhengye Biotechnology Holding Limited's long-term debt history and peer comparisons.
Zhengye Biotechnology Holding Limited's long-term debt increased from $4.8M to $9.2M — a 91.2% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Zhengye Biotechnology Holding Limited reported $9.2M in long-term debt as of December 2025. That compares with $4.8M in the prior-year period — up 91.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current long-term debt of $9.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zhengye Biotechnology Holding Limited, and consider following ZYBT for alerts when major investors trade the stock.